Sirio Pharma Free Cash Flow Generation Index
Sirio Pharma free cash flow generation index. Sirio Pharma (300791) has a Free Cash Flow Generation Index of 0.41x as of June 2023. Free cash flow of CN¥41.96 Million represents 0% of operating cash flow (CN¥101.61 Million). Check financial resilience of Sirio Pharma to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Sirio Pharma (2017–2024)
Free cash flow generation index of Sirio Pharma from 2017 to 2024. Historical FCF Generation Index trend for Sirio Pharma across 8 annual periods. Explore reinvestment intensity of Sirio Pharma to see what proportion of operating cash flow is directed to capital expenditures.
Sirio Pharma Free Cash Flow Generation Index by Year (2017–2024)
Sirio Pharma free cash flow generation index by year from 2017 to 2024. Year-by-year Free Cash Flow Generation Index for Sirio Pharma. For the full cash flow conversion analysis, see Sirio Pharma (300791) cash conversion ratio.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.27x | CN¥154.84 Million | CN¥566.97 Million | CN¥412.13 Million | ▲ +260.7% |
| 2023 | -0.17x | CN¥-65.62 Million | CN¥386.08 Million | CN¥451.70 Million | ▼ -150.0% |
| 2022 | 0.34x | CN¥151.17 Million | CN¥444.86 Million | CN¥293.69 Million | ▲ +163.3% |
| 2021 | -0.54x | CN¥-183.31 Million | CN¥341.38 Million | CN¥524.68 Million | ▼ -278.0% |
| 2020 | 0.30x | CN¥96.43 Million | CN¥319.57 Million | CN¥223.14 Million | ▲ +8.0% |
| 2019 | 0.28x | CN¥64.71 Million | CN¥231.60 Million | CN¥166.90 Million | ▲ +191.7% |
| 2018 | -0.30x | CN¥-55.87 Million | CN¥183.46 Million | CN¥239.32 Million | ▲ +86.4% |
| 2017 | -2.24x | CN¥-110.47 Million | CN¥49.35 Million | CN¥159.82 Million | — |